^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Prostate Cancer |
| Drug: | abiraterone acetate (CYP17A1 inhibitor) + dexamethasone (GCR agonist) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
07/17/2023
Excerpt:
Prostate Cancer: Other recommended regimens…Abiraterone + dexamethasone….
